Clinical trial · Observational
ColoRectal Cancer in India: catastrOphiC expenDIture and Referral Pathways infLuencE on Presentation and Treatment
NCT04517032CI-TRIAL-00046672CROCODILEunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Observational study to assess barriers for colorectal cancer treatment compliance in India, including quantitative assessment of catastrophic expenditure incidence and qualitative assessment of financial and non-financial barriers.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
| Health Care Utilization | — | UNRESOLVED | — |
| Treatment Compliance | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Catastrophic Expenditure at 6 months
- timeFrame
- 6 months after treatment decision
- description
- Catastrophic expenditure (CE) will be defined as out of pocket payments for CRC treatment greater than 40% of patient income (assessed by an in-person questionnaire led by a researcher).
Secondary outcomes (7)
- measure
- Catastrophic Expenditure at 6 weeks
- timeFrame
- 6 weeks after treatment decision
- description
- Catastrophic expenditure (CE) will be defined as out of pocket payments for CRC treatment greater than 40% of patient income (assessed by an in-person questionnaire led by a researcher).
- measure
- Catastrophic Expenditure at 3 months
- timeFrame
- 3 months after treatment decision
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria * Adults aged 18+ years old. AND * Consecutive new patients with a histopathology proven colorectal cancer for whom a CRC treatment plan is made: * In an multi-disciplinary team meeting (MDT); * OR in the outpatient clinic where an MDT is not available (surgery, oncology or radiotherapy outpatient clinic). AND • Undergoing treatment in the hospital where the MDT took place Exclusion Criteria * Patients with no histopathology available * Telephone follow-up not possible
References
Publications (0)
Data not yet available
No reference posted for this study.